Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences 3D-Printing in the Life Sciences, Biofabrication & Synthetic Biology

Fabien Guillemot's Biography



Fabien Guillemot, Chief Executive Officer, Poietis

Dr. Fabien Guillemot is the CEO and founder of Poietis, company devoted to the fabrication of complex and customized tissues for regenerative medicine and pharmaceutical applications by Laser-Assisted Bioprinting. He obtained his PhD in Materials Science in 2000 from the National Institute for Applied Sciences (France) and was appointed Senior Researcher in 2005 at the National Institute for Health and Medical Research (INSERM, France). PI of the group Tissue Engineering Assisted by Laser, he accomplished pioneered works on in vivo and in situ bioprinting. In 2009, Dr. Guillemot organized the International Conference on Bioprinting and Biofabrication in Bordeaux. He is the author of more than 50 articles in peer-reviewed journals and about 40 invited conferences.

Fabien Guillemot Image

4D Bioprinting: Programming Self-Organization to Engineer Biological Tissues

Friday, 18 March 2016 at 09:00

Add to Calendar ▼2016-03-18 09:00:002016-03-18 10:00:00Europe/London4D Bioprinting: Programming Self-Organization to Engineer Biological TissuesSELECTBIOenquiries@selectbiosciences.com

Bioprinting has been defined as “the use of computer-aided transfer processes for patterning and assembling living and non-living materials with a prescribed 2D or 3D organization in order to produce bio-engineered structures serving in regenerative medicine, pharmacokinetic and basic cell biology studies”. From a technological point of view, the Laser-Assisted Bioprinting (LAB) technology has emerged as an alternative method to inkjet and bioextrusion methods, thereby overcoming some of their limitations (namely clogging of print heads or capillaries) to pattern living cells and biomaterials with a micron-scale resolution and high cell viability. By harnessing this high cell printing resolution, we observe that tissue self-organization depends on the cell patterns initially printed by LAB, as well as cell types. We introduce from experiments performed in vitro and in vivo the 4D Bioprinting paradigm.


Add to Calendar ▼2016-03-17 00:00:002016-03-18 00:00:00Europe/London3D-Printing in the Life Sciences, Biofabrication and Synthetic BiologySELECTBIOenquiries@selectbiosciences.com